IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure.

calibration certified reference material commutability harmonization standardization traceability

Journal

Clinical chemistry
ISSN: 1530-8561
Titre abrégé: Clin Chem
Pays: England
ID NLM: 9421549

Informations de publication

Date de publication:
01 06 2020
Historique:
received: 02 10 2019
accepted: 06 02 2020
pubmed: 27 4 2020
medline: 31 3 2021
entrez: 27 4 2020
Statut: ppublish

Résumé

Establishing metrological traceability to an assigned value of a matrix-based certified reference material (CRM) that has been validated to be commutable among available end-user measurement procedures (MPs) is central to producing equivalent results for the measurand in clinical samples (CSs) irrespective of the clinical laboratory MPs used. When a CRM is not commutable with CSs, the bias due to noncommutability will be propagated to the CS results causing incorrect metrological traceability to the CRM and nonequivalent CS results among different MPs. In a commutability assessment, a conclusion that a CRM is commutable or noncommutable for use with a specific MP is made when the difference in bias between the CRM and CSs meets or does not meet a criterion for that specific MP when compared to other MPs. A conclusion regarding commutability or noncommutability requires that the magnitude of the difference in bias observed in the commutability assessment remains unchanged over time. This conclusion requires the CRM to be stable and no substantive changes in the MPs. These conditions should be periodically reverified. If an available CRM is determined to be noncommutable for a specific MP, that CRM can be used in the calibration hierarchy for that MP when an appropriately validated MP-specific correction for the noncommutability bias is included. We describe with examples how a MP-specific correction and its uncertainty can be developed and applied in a calibration hierarchy to achieve metrological traceability of results for CSs to the CRM's assigned value.

Identifiants

pubmed: 32335671
pii: 5825330
doi: 10.1093/clinchem/hvaa048
pmc: PMC7551486
mid: NIHMS1633420
doi:

Substances chimiques

Reagent Kits, Diagnostic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-778

Subventions

Organisme : Intramural NIST DOC
ID : 9999-NIST
Pays : United States

Informations de copyright

© American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Anal Bioanal Chem. 2010 May;397(2):521-5
pubmed: 19921156
Clin Chem. 2011 Dec;57(12):1776-7
pubmed: 21986893
Clin Chim Acta. 1998 May 25;273(2):103-17
pubmed: 9657342
Clin Chem. 2009 Jun;55(6):1067-75
pubmed: 19359540
Clin Chem Lab Med. 2015 May;53(6):833-5
pubmed: 25719329
Clin Chem. 2006 Apr;52(4):553-4
pubmed: 16595820
Clin Chem. 2017 Mar;63(3):770-779
pubmed: 28073902
J Res Natl Inst Stand Technol. 1998 Jan-Feb;103(1):93-105
pubmed: 28009372
Arch Pathol Lab Med. 2005 Mar;129(3):310-7
pubmed: 15737023
Clin Chem. 2018 Mar;64(3):447-454
pubmed: 29348163
Clin Chem. 2018 Mar;64(3):455-464
pubmed: 29348165
Clin Chim Acta. 2017 Apr;467:42-47
pubmed: 27746210
Clin Chem. 2010 Jun;56(6):902-11
pubmed: 20395624
Clin Chem. 2009 May;55(5):1011-8
pubmed: 19325009
Ann Clin Biochem. 2012 Jan;49(Pt 1):63-7
pubmed: 22096021
Clin Chem. 2018 Mar;64(3):465-474
pubmed: 29348164
Clin Chem Lab Med. 2015 May;53(6):905-12
pubmed: 25870964
Clin Chim Acta. 2014 May 15;432:72-6
pubmed: 24508625
Clin Chem. 2004 Sep;50(9):1711-2
pubmed: 15331520
Clin Chem. 2013 Sep;59(9):1322-9
pubmed: 23649128
Clin Biochem. 2018 Jul;57:7-11
pubmed: 29526674
Clin Biochem. 2018 Jul;57:23-28
pubmed: 29428441

Auteurs

W Greg Miller (WG)

Virginia Commonwealth University, Richmond, VA.

Jeffrey Budd (J)

Jeff Budd Consulting, St. Paul, MN.

Neil Greenberg (N)

Neil Greenberg Consulting, LLC, Rochester, NY.

Cas Weykamp (C)

Queen Beatrix Hospital, Winterswijk, the Netherlands.

Harald Althaus (H)

Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany.

Heinz Schimmel (H)

European Commission, Joint Research Centre, Directorate F, Geel, Belgium.

Mauro Panteghini (M)

Research Centre for Metrological Traceability in Laboratory Medicine (CIRME), University of Milan, Milan, Italy.

Vincent Delatour (V)

Laboratoire national de métrologie et d'essais (LNE), Paris, France.

Ferruccio Ceriotti (F)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Thomas Keller (T)

ACOMED Statistic, Leipzig, Germany.

Douglas Hawkins (D)

School of Statistics, University of Minnesota, Minneapolis, MN.

Chris Burns (C)

National Institute for Biological Standards and Control, A Centre of the MHRA, Hertfordshire, UK.

Robert Rej (R)

Wadsworth Center for Laboratories and Research, New York State Department of Health, and School of Public Health State University of New York at Albany, Albany, NY.

Johanna E Camara (JE)

National Institute of Standards and Technology, Gaithersburg, MD.

Finlay MacKenzie (F)

Birmingham Quality/UK NEQAS, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Eline van der Hagen (E)

Queen Beatrix Hospital, Winterswijk, the Netherlands.

Hubert Vesper (H)

Centers for Disease Control and Prevention, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH